Ovarian Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Ovarian Cancer, including details on symptoms, causes, treatment, information.

Volume 3 (2006), Issue 9 (September)

1. SET complex in serous epithelial ovarian cancer.
   Int J Cancer, 119(9): 2119-26. [Abstract] [Full-text]
2. Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies.
   Int J Cancer, 119(9): 2148-54. [Abstract] [Full-text]
3. T-cell immunity to the folate receptor alpha is prevalent in women with breast or ovarian cancer.
   J Clin Oncol, 24(26): 4254-61. [Abstract] [Full-text]
4. ErbB-3 predicts survival in ovarian cancer.
   J Clin Oncol, 24(26): 4317-23. [Abstract] [Full-text]
5. Clinical activity of pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in advanced ovarian cancer: potential predictive relationship with tumor HER2 activation status.
   J Clin Oncol, 24(26): 4324-32. [Abstract] [Full-text]
6. Image guided biopsy in the management of cancer of the ovary.
   Cancer Imaging, 6: 144-7. [Abstract] [Full-text]
7. Comparative genome hybridization reveals specific genomic imbalances during the genesis from benign through borderline to malignant ovarian tumors.
   Cancer Genet Cytogenet, 170(1): 1-8. [Abstract] [Full-text]
8. MRI appearance of primary giant ovarian leiomyoma in a hysterectomised woman.
   Br J Radiol, 79(946): e126-8. [Abstract] [Full-text]
9. Ovarian Sertoli-Leydig cell tumor of intermediate grade with heterologous elements of rhabdomyosarcoma. A case report and a review of the literature.
   Ann Diagn Pathol, 10(5): 288-93. [Abstract] [Full-text]
10. Receptor tyrosine kinase (RTK) inhibition is effective in chemosensitising EGFR-expressing drug resistant human ovarian cancer cell lines when used in combination with cytotoxic agents.
    Biochem Pharmacol, 72(8): 941-8. [Abstract] [Full-text]
11. Impact of different pressures and exposure times of a simulated carbon dioxide pneumoperitoneum environment on proliferation and apoptosis of human ovarian cancer cell lines.
    Surg Endosc, 20(10): 1556-9. [Abstract] [Full-text]
12. Pathogenesis of balls in mature ovarian cystic teratoma. Report of 3 cases and review of literature.
    Int J Gynecol Pathol, 25(4): 347-53. [Abstract] [Full-text]
13. Pseudomyxoma peritonei associated with a mucinous ovarian tumor arising from a mature cystic teratoma. A case report.
    Int J Gynecol Pathol, 25(4): 340-3. [Abstract] [Full-text]
14. Ovarian serous cystadenofibroma with stromal sex cord elements: report of a unique case.
    Int J Gynecol Pathol, 25(4): 336-9. [Abstract] [Full-text]
15. Expression of claudins 1, 4, 5, and 7 in ovarian tumors of diverse types.
    Int J Gynecol Pathol, 25(4): 330-5. [Abstract] [Full-text]
16. Primary malignant melanoma of the ovary: a report of 9 definite or probable cases with emphasis on their morphologic diversity and mimicry of other primary and secondary ovarian neoplasms.
    Int J Gynecol Pathol, 25(4): 321-9. [Abstract] [Full-text]
17. Recent advances in the pathology and classification of ovarian germ cell tumors.
    Int J Gynecol Pathol, 25(4): 305-20. [Abstract] [Full-text]
18. Unfavorable prognostic value of human kallikrein 7 quantified by ELISA in ovarian cancer cytosols.
    Clin Chem, 52(10): 1879-86. [Abstract] [Full-text]
19. Patterns of stromal invasion in ovarian serous tumors of low malignant potential (borderline tumors): a reevaluation of the concept of stromal microinvasion.
    Am J Surg Pathol, 30(10): 1209-21. [Abstract] [Full-text]
20. Saxatilin inhibits TNF-alpha-induced proliferation by suppressing AP-1-dependent IL-8 expression in the ovarian cancer cell line MDAH 2774.
    Mol Immunol, 44(6): 1409-16. [Abstract] [Full-text]

© 2004-2008 Ovarian Cancer Research Today. All Rights Reserved.